Pages that link to "Q35083548"
Jump to navigation
Jump to search
The following pages link to Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. (Q35083548):
Displaying 50 items.
- The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7 (Q24292473) (← links)
- Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination (Q24306353) (← links)
- Multiple system atrophy: cellular and molecular pathology (Q24535446) (← links)
- Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy (Q24654614) (← links)
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease (Q27014051) (← links)
- Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease (Q28210040) (← links)
- TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates (Q28211766) (← links)
- Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G (Q28267535) (← links)
- Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease (Q28391273) (← links)
- CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism (Q28579022) (← links)
- Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease (Q28863269) (← links)
- Parkinson's disease: mechanisms and models (Q29547424) (← links)
- Methylpyridinium (MPP( ))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells (Q30310043) (← links)
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease. (Q30444758) (← links)
- A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain (Q31071712) (← links)
- Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model (Q31137569) (← links)
- Dopaminergic cell death induced by MPP( ), oxidant and specific neurotoxicants shares the common molecular mechanism (Q31961819) (← links)
- Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences (Q33280786) (← links)
- Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. (Q33304994) (← links)
- En1 and Wnt signaling in midbrain dopaminergic neuronal development (Q33351225) (← links)
- GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons (Q33602001) (← links)
- Endoplasmic reticulum stress and inflammation in the central nervous system (Q33730922) (← links)
- Secalonic acid A reduced colchicine cytotoxicity through suppression of JNK, p38 MAPKs and calcium influx (Q33745861) (← links)
- Calbindin-D28K Prevents Staurosporin-induced Bax Cleavage and Membrane Permeabilization (Q33787359) (← links)
- Pathology dynamics predict spinal cord injury therapeutic success (Q33805235) (← links)
- Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease (Q33943273) (← links)
- An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease (Q33943954) (← links)
- Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease (Q33951094) (← links)
- Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases (Q34063565) (← links)
- Anamorsin, a novel caspase-3 substrate in neurodegeneration (Q34070411) (← links)
- Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. (Q34117201) (← links)
- Pharmacogenomics of neurodegenerative diseases (Q34137788) (← links)
- Experimental models of Parkinson's disease (Q34238077) (← links)
- Does neuronal loss in Parkinson's disease involve programmed cell death? (Q34312949) (← links)
- Caspase-dependent apoptotic pathways in CNS injury (Q34520118) (← links)
- Exploring key orientations at protein-protein interfaces with small molecule probes (Q34524107) (← links)
- Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration (Q34583071) (← links)
- Emerging therapies in the pharmacological treatment of Parkinson's disease (Q34585156) (← links)
- Cell death mechanisms in neurodegeneration. (Q34687641) (← links)
- Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats (Q34688621) (← links)
- Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease (Q34722724) (← links)
- Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease (Q34802038) (← links)
- Apoptotic molecules and MPTP-induced cell death (Q34802059) (← links)
- Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes (Q34802158) (← links)
- The Mitochondrial Permeability Transition Pore Regulates Nitric Oxide-Mediated Apoptosis of Neurons Induced by Target Deprivation (Q34806557) (← links)
- Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss (Q35007941) (← links)
- Glial cell response: A pathogenic factor in Parkinson's disease. (Q35022863) (← links)
- Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation (Q35043731) (← links)
- Caspase inhibitors as anti-inflammatory and antiapoptotic agents. (Q35049064) (← links)
- Gene discovery and validation for neurodegenerative diseases (Q35053214) (← links)